Moreover, in GC, ARHGAP5-AS1 promotes the upregulation of its target gene ARHGAP5 and regulates the m6A-autophagy axis, thereby promoting drug resistance in tumor cells [103]. This evidence concerns the gene ARHGAP5 and neoplasm.